Werewolf Therapeutics Inc (OQ:HOWL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for HOWL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 18th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Series B Preferred Stock C - Conversion -6,621,546  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Series A Preferred Stock C - Conversion -19,925,321  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock P - Open market or private purchase 125,759 $16.00
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock C - Conversion 763,809  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock C - Conversion 2,298,430  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Series B Preferred Stock C - Conversion -12,899,925  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Series A Preferred Stock C - Conversion -38,817,998  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock P - Open market or private purchase 245,000 $16.00
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock C - Conversion 1,488,033  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock C - Conversion 4,477,742  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for HOWL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 18th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Series B Preferred Stock C - Conversion -6,621,546  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Series A Preferred Stock C - Conversion -19,925,321  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock P - Open market or private purchase 125,759 $16.00
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock C - Conversion 763,809  
May 6/21 May 4/21 MPM BioVentures 2014, L.P. Indirect Ownership Common Stock C - Conversion 2,298,430  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Series B Preferred Stock C - Conversion -12,899,925  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Series A Preferred Stock C - Conversion -38,817,998  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock P - Open market or private purchase 245,000 $16.00
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock C - Conversion 1,488,033  
May 6/21 May 4/21 Gadicke Ansbert Indirect Ownership Common Stock C - Conversion 4,477,742  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $HOWL

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Syneos Health (OQ:SYNH)
Crispr Therapeutics AG (OQ:CRSP)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.